News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Rob Stein, Washington Post | 01.06.2007

A Texas company has started producing batches of ready-made embryos that single women and infertile couples can order after reviewing...

By Marisa Taylor, Red Herring | 01.05.2007

The United Kingdom's regulatory body for stem cell and fertility research will vote Wednesday to determine whether a team of...

By Biotechnology Australia, Biotechnology Australia | 01.01.2007

Are these technologies likely to improve our way of life in the future, have no effect or make things worse...

By Polly Curtis, The Guardian (UK) | 12.30.2006

Scientists have unveiled a new form of IVF which they claim is "better than nature" at getting some women pregnant...

By Kit Wagar, Kansas City Star | 12.20.2006

Surrounded by boisterous supporters, state Sen. Matt Bartle and Rep. Jim Lembke unveiled their proposal Tuesday to reverse last month’s...

By Sonya Geis, Washington Post | 12.19.2006

LOS ANGELES -- Two years after California voters passed a landmark $3 billion bond measure for stem cell research, not...

By Mark Henderson, Times Online | 12.18.2006

The medical promise of therapeutic cloning has been oversold and its unreasonably high profile risks turning the public against more...